Table 5.
EG N = 142 (n, %) | EGE N = 123 (n, %) | EC N = 108 (n, %) | P-value | |
---|---|---|---|---|
Medications | ||||
PPI | 86 (61%) | 74 (60%) | 32 (30%) | < 0.001 |
Topical corticosteroids | 33 (23%) | 24 (20%) | 11 (10%) | 0.008 |
Systemic corticosteroids | 28 (20%) | 30 (24%) | 20 (19%) | 0.34 |
Crushed enteric coated budesonide | 18 (13%) | 12 (10%) | 21 (19%) | 0.016 |
5-ASA | 1 (1%) | 4 (3%) | 27 (25%) | < 0.001 |
Immune modulating drug | 5 (4%) | 4 (3%) | 8 (7%) | 0.34 |
Mast cell agent | 1 (1%) | 2 (2%) | 4 (4%) | 0.65 |
Monoclonal antibody | 2 (1%) | 4 (3%) | 1 (1%) | 0.15 |
Diet Modification | ||||
Six-food elimination | 5 (4%) | 2 (2%) | 6 (6%) | 0.43 |
Allergen specific elimination | 62 (44%) | 62 (50%) | 43 (40%) | 0.31 |
Elemental diet | 15 (11%) | 20 (16%) | 12 (11%) | 0.17 |
Six food elimination included restriction of cow’s milk, hen’s egg, soy, wheat, nuts, fish, and shellfish. Data shown as number (n) and % of specific population. P-value considered significant if < 0.05. EG: eosinophilic gastritis, EGE: eosinophilic gastroenteritis, EC: eosinophilic colitis, EGID: eosinophilic gastrointestinal disorder, PPI: proton-pump inhibitor, 5-ASA: 5-aminosalicyclic acid.